Q13 Continuous Manufacturing of Drug Substances and Drug Products: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 1, 2023
March 1, 2023
2724500a-92c1-4369-92e2-13983181dbcf
Related Documents
Identification of Medicinal Products — Implementation and Use
Guidance DocumentMarch 30, 2023Center for Drug Evaluation and Research
Clinical Pharmacology Considerations for Antibody-Drug Conjugates Guidance for Industry: Guidance for Industry
Guidance DocumentMarch 1, 2024Center for Drug Evaluation and Research
Benefit-Risk Assessment for New Drug and Biological Products
Guidance DocumentOctober 17, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox